Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. This morning clinical-stag...

NU Skin Shares Climb 25% Higher on Strong Quarterly Global Customer and Revenue Growth

NU Skin Enterprises reported that preliminary Q2/20 revenue exceeded previously forecasted estimates and that the company is experiencing stronger than expected global growth along with accelerated digital adoption. Direct selling company NU Skin Enterprises Inc. ...

How Machine Learning Will Affect E-commerce Industry in near future

Machine learning and artificial intelligence have in one way or the other, immensely contributed to bringing e-commerce to a value of $2.3 trillion in the market. Machine learning brought a revolution in the said field by helping merchants better analyse their businesse...

Coverage Initiated on Producer of Hemp-Derived Cannabidiol Products

A ROTH Capital Partners report presented the reasons for investing in this company. In a March 7 research note, analyst Scott Fortune reported that ROTH Capital Partners initiated coverage on Charlotte's Web Holdings Inc. (CWEB:CSE; CWBHF:OTCQX) with a Buy rating and ...

Biopharma Continues 'Positive Push Forward in Breast Cancer'

The latest clinical trial results and next step are reviewed in an H.C. Wainwright & Co. report. In a Dec. 26 research note, analyst Joseph Pantginis reported that H.C. Wainwright & Co. increased its target price to AU$0.20 from AU$0.16 and maintained its Buy recommen...

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. This morning, Hamilton, Bermuda based biopharmaceutical comp...

Triumph Gold, TUI, wallstreet:online - Special situations with potential

Two stock splits are scheduled for next week, which will be the focus of investors. This type of capital measure is usually chosen to make the share price look good again and thereby increase the trading volume. In the case of Apple ( NASDAQ: AAPL ), one share becomes four n...

Buzz on the Bullboards: TSX recovering as key stocks eye a comeback

The TSX has been on a rebound, clawing back to levels seen before the great global selloff that marked the beginning of the month. As the market stabilizes, investors are keenly watching certain TSX-listed stocks that have recently faced setbacks but are striving to reg...

Desert Gold Ventures - A jewel for the investor?

With geopolitical tensions, a potential gold-backed BRICS currency, and declining interest rates, gold is experiencing a true renaissance – and the recent rally, which pushed the price towards US$2,800 per ounce, has sparked investor interest like never before. As the go...

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer

Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specifi...
1 2 3 4 5 6 7 8 9 10 ...